/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
Specialty drugs are fast becoming a lucrative market globally. And India’s largest drugmaker has done well to make the most of this opportunity so far. But it’s too soon to rest easy.
What connects American actress Jada Pinkett Smith and Indian drugmaker Sun Pharmaceutical Industries?
In 2022, Pinkett Smith, who suffers from a hair-loss condition, found herself at the centre of one the most shocking incidents in the history of the Oscars. At the 94th Academy Awards ceremony, actor and Pinkett Smith’s husband Will Smith smacked presenter Chris Rock. The latter had made a joke about Pinkett Smith’s bald head.
What does this have to do with Sun Pharma? A simple answer is alopecia areata. Last week, India’s largest pharma company by revenue got the US Food and Drug Administration’s nod for …
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
